Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
Xenetic Biosciences, Inc. (XBIO) stock — financials, valuation and filings | Moatkeep
Companies
/
Nasdaq
/
XBIO
Xenetic Biosciences, Inc.
XBIO · Nasdaq
$1.66
−11.05%
Close, 2026-11-12
Close, 2026-11-12 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Data under review
Price
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
NV
Fiscal year end
Dec 31
Financials · latest year
USD millions
FY2025
Revenue
3
Net Income
-3
FY2024
•••••
•••••
FY2023
•••••
•••••
FY2022
•••••
•••••
FY2021
•••••
•••••
Read the full financial statements
Create a free account to see 5 years of financial history
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
SCKT
—
SOCKET MOBILE, INC.
TCRX
—
TScan Therapeutics, Inc.
PMCB
—
PharmaCyte Biotech, Inc.
KALA
—
KALA BIO, Inc.
XAIR
—
Beyond Air, Inc.
IMNN
—
Imunon, Inc.
GELS
—
Gelteq Ltd
DRMA
—
Dermata Therapeutics, Inc.